These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6810534)

  • 21. Identification of RNA species in the RNA-toxin complex and structure of the complex in Clostridium botulinum type E.
    Kitamura M
    Biochem Biophys Res Commun; 2002 Feb; 291(1):154-7. PubMed ID: 11829476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid detection and quantitative estimation of type A botulinum toxin by electroimmunodiffusion.
    Miller CA; Anderson AW
    Infect Immun; 1971 Aug; 4(2):126-9. PubMed ID: 5005291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of different methods for the serological determination of alpha1-foetoprotein in serum (author's transl)].
    Lehmann FG; Lehmann D
    Z Klin Chem Klin Biochem; 1973 Aug; 11(8):339-47. PubMed ID: 4356286
    [No Abstract]   [Full Text] [Related]  

  • 24. Production and purification of the heavy-chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotrophic yeast Pichia pastoris.
    Potter KJ; Bevins MA; Vassilieva EV; Chiruvolu VR; Smith T; Smith LA; Meagher MM
    Protein Expr Purif; 1998 Aug; 13(3):357-65. PubMed ID: 9693060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification of three fragments of the dermonecrotic toxin from Pasteurella multocida.
    Nakai T; Kume K
    Res Vet Sci; 1987 Mar; 42(2):232-7. PubMed ID: 3108979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Isolation and characteristics of highly-purified phenylalanine hydroxylase from the rat liver].
    Chestkov VV; Kugukova IuV; Kovalev LI; Shishkin SS
    Vopr Med Khim; 1986; 32(1):123-7. PubMed ID: 3953006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Production, purification, and characterization of botulinolysin, a thiol-activated hemolysin of Clostridium botulinum.
    Haque A; Sugimoto N; Horiguchi Y; Okabe T; Miyata T; Iwanaga S; Matsuda M
    Infect Immun; 1992 Jan; 60(1):71-8. PubMed ID: 1729198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Amino acid composition of major components of Cl. botulinum toxin of type B].
    Kliucheva VV; Saprykina TP; Dolgikh MS; Blagoveshchenskiĭ VA
    Vopr Med Khim; 1982; 28(5):29-33. PubMed ID: 6758340
    [No Abstract]   [Full Text] [Related]  

  • 29. [Immunochemical properties of secretory IgA of human colostrum].
    Scavini LM; Alonso A; Rodríguez S
    Allergol Immunopathol (Madr); 1980; 8(1):15-22. PubMed ID: 6967687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of human prostatic acid phosphatase and preparation of a specific antiserum in the rabbit.
    Paoli C; Rinaldi F; Tarli P; Neri P
    Ital J Biochem; 1981; 30(3):242-50. PubMed ID: 6792106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of antibodies against botulinum toxins.
    Sesardic D; Jones RG; Leung T; Alsop T; Tierney R
    Mov Disord; 2004 Mar; 19 Suppl 8():S85-91. PubMed ID: 15027059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Homogeneity and heterogeneity of toxins produced by Clostridium botulinum type C and D strains.
    Oguma K; Syuto B; Agui T; Iida H; Kubo S
    Infect Immun; 1981 Nov; 34(2):382-8. PubMed ID: 6171518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and characterization of two components of botulinum C2 toxin.
    Ohishi I; Iwasaki M; Sakaguchi G
    Infect Immun; 1980 Dec; 30(3):668-73. PubMed ID: 6785232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Isolation and characterization of the polypeptide fragments obtained by limited proteolysis of botulinic toxin type A].
    Shibaeva IV; Kolesnikova VA; Kazdobina IS; Ivanov KK
    Biokhimiia; 1980 Sep; 45(9):1589-96. PubMed ID: 6788094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of type A botulinal toxin assays that use antitoxin to crystalline toxin.
    Sugiyama H; Oishi I; Dasgupta BR
    Appl Microbiol; 1974 Feb; 27(2):333-6. PubMed ID: 4856714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and comparison of rabbit blastokinin produced under various physiological and experimental conditions.
    Garcea N; Porcelli G; Caruso A; Campo S; Bompiani A
    Int J Fertil; 1974; 19(2):73-9. PubMed ID: 4370624
    [No Abstract]   [Full Text] [Related]  

  • 37. Difficulties of molecular dissociation of Clostridium botulinum type G progenitor toxin.
    Nukina M; Mochida Y; Sakaguchi S; Sakaguchi G
    FEMS Microbiol Lett; 1991 Apr; 63(2-3):165-70. PubMed ID: 1905655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium botulinum type E toxin: effect of pH and method of purification on molecular weight.
    Sacks HS; Covert SV
    Appl Microbiol; 1974 Sep; 28(3):374-82. PubMed ID: 4609265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new scaleable method for the purification of botulinum neurotoxin type E.
    Gessler F
    J Biotechnol; 2005 Sep; 119(2):204-11. PubMed ID: 15885835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of polyclonal antibodies in mice against cobratoxin, botulinum toxin and ricin without altering their toxicity or use of adjuvant.
    Lipps BV
    J Nat Toxins; 2001 Feb; 10(1):27-32. PubMed ID: 11288726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.